|
Enzyme
key to toxoplasma pathology
Dartmouth Medical School geneticists in the Department of Microbiology
and Immunology have discovered how to weaken a common human parasite
to prevent disease in an animal model after infection by the normal
parasite.
ImmunoGen,
Millennium sign exclusive product licence
ImmunoGen, Inc has announced that the Company and Millennium Pharmaceu-ticals,
Inc have signed an exclusive product license for use of ImmunoGen’s
proprietary maytansinoid Tumour-Activated Prodrug (TAP) technology
with Millennium’s MLN591 antibody.
|
